BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38677765)

  • 21. Comparison of lymphatic contrast-enhanced ultrasound and intravenous contrast-enhanced ultrasound in the preoperative diagnosis of axillary sentinel lymph node metastasis in patients with breast cancer.
    Zhuang L; Ming X; Liu J; Jia C; Jin Y; Wang J; Shi Q; Wu R; Jin L; Du L
    Br J Radiol; 2022 Feb; 95(1130):20210897. PubMed ID: 34797694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
    Foster D; Choy N; Porter C; Ahmed S; Wapnir I
    J Surg Oncol; 2018 Mar; 117(3):336-340. PubMed ID: 29228459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does Contrast Enhanced Ultrasound (CEUS) of Normal/Benign Axillary Lymph Nodes in Patients with Breast Cancer Identify Significant Axillary Nodal Burden?
    Nielsen Moody A; Cox K; Haigh I; Chen Y; Sharma N
    Eur J Radiol; 2020 Nov; 132():109311. PubMed ID: 33017774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer.
    DeSnyder SM; Mittendorf EA; Le-Petross C; Krishnamurthy S; Whitman GJ; Ueno NT; Woodward WA; Kuerer HM; Akay CL; Babiera GV; Yang W; Lucci A
    Clin Breast Cancer; 2018 Feb; 18(1):e73-e77. PubMed ID: 28755879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preliminary study of real-time three-dimensional contrast-enhanced ultrasound of sentinel lymph nodes in breast cancer.
    Hu Z; Cheng X; Li J; Jiang J; Jiang Z; Li H; Li T; Zhang Z; Tan B; Lu M
    Eur Radiol; 2020 Mar; 30(3):1426-1435. PubMed ID: 31776739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel Less-invasive Approach for Axillary Staging After Neoadjuvant Chemotherapy in Patients With Axillary Node-positive Breast Cancer by Combining Radioactive Iodine Seed Localization in the Axilla With the Sentinel Node Procedure (RISAS): A Dutch Prospective Multicenter Validation Study.
    van Nijnatten TJA; Simons JM; Smidt ML; van der Pol CC; van Diest PJ; Jager A; van Klaveren D; Kam BLR; Lobbes MBI; de Boer M; Verhoef K; Koppert LB; Luiten EJT
    Clin Breast Cancer; 2017 Aug; 17(5):399-402. PubMed ID: 28487053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy.
    Han SN; Amant F; Cardonick EH; Loibl S; Peccatori FA; Gheysens O; Sangalli CA; Nekljudova V; Steffensen KD; Mhallem Gziri M; Schröder CP; Lok CAR; Verest A; Neven P; Smeets A; Pruneri G; Cremonesi M; Gentilini O;
    Breast Cancer Res Treat; 2018 Apr; 168(2):551-557. PubMed ID: 29235045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast lymphoscintigraphy for sentinel node identification in breast cancers with clinically-negative axillary nodes.
    Namwongprom S; Boonyaprapa S; Ekmahachai M; Vilasdechanon N; Somwangprasert A; Sumitsawan S; Taya P
    Singapore Med J; 2005 Dec; 46(12):688-92. PubMed ID: 16308641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced axillary assessment using intradermally injected microbubbles and contrast-enhanced ultrasound (CEUS) before neoadjuvant systemic therapy (NACT) identifies axillary disease missed by conventional B-mode ultrasound that may be clinically relevant.
    Cox K; Dineen N; Taylor-Phillips S; Sharma N; Harper-Wynne C; Allen D; Weeks J; Chalmers R; Akolekar D; Burcombe R; Jyothirmayi R; Sever A
    Breast Cancer Res Treat; 2021 Jan; 185(2):413-422. PubMed ID: 33029707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast-enhanced ultrasonography and blue dye methods in detection of sentinel lymph nodes following neoadjuvant chemotherapy in initially node positive breast cancer.
    Wu X; Tang L; Huang W; Huang S; Peng W; Hu D
    Arch Gynecol Obstet; 2020 Sep; 302(3):685-692. PubMed ID: 32602000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary study of contrast-enhanced ultrasound in combination with blue dye vs. indocyanine green fluorescence, in combination with blue dye for sentinel lymph node biopsy in breast cancer.
    Zhou Y; Li Y; Mao F; Zhang J; Zhu Q; Shen S; Lin Y; Zhang X; Liu H; Xiao M; Jiang Y; Sun Q
    BMC Cancer; 2019 Oct; 19(1):939. PubMed ID: 31604469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sentinel lymph node biopsy alone without axillary lymph node dissection--follow up of sentinel lymph node negative breast cancer patients.
    Reitsamer R; Peintinger F; Prokop E; Menzel C; Cimpoca W; Rettenbacher L
    Eur J Surg Oncol; 2003 Apr; 29(3):221-3. PubMed ID: 12657230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sentinel node detection method using contrast-enhanced ultrasonography with sonazoid in breast cancer: preliminary clinical study.
    Omoto K; Matsunaga H; Take N; Hozumi Y; Takehara M; Omoto Y; Shiozawa M; Mizunuma H; Harashima H; Taniguchi N; Kawano M
    Ultrasound Med Biol; 2009 Aug; 35(8):1249-56. PubMed ID: 19520493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast-enhanced ultrasound for sentinel lymph node mapping in the routine staging of canine mast cell tumours: A feasibility study.
    Fournier Q; Thierry F; Longo M; Malbon A; Cazzini P; Bisson J; Woods S; Liuti T; Bavcar S
    Vet Comp Oncol; 2021 Sep; 19(3):451-462. PubMed ID: 32840038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience of sentinel node biopsy alone in early breast cancer without further axillary dissection in patients with negative sentinel node.
    Soni NK; Spillane AJ
    ANZ J Surg; 2005 May; 75(5):292-9. PubMed ID: 15932439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of sentinel node re-mapping in patients who have second or recurrent breast cancer and had previous axillary procedures.
    Tokmak H; Kaban K; Muslumanoglu M; Demirel M; Aktan S
    World J Surg Oncol; 2014 Jul; 12():205. PubMed ID: 25016393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection and Characterization of Sentinel Lymph Node by Ultrasound Molecular Imaging with B7-H3-Targeted Microbubbles in Orthotopic Breast Cancer Model in Mice.
    Hu Z; Bachawal SV; Li X; Wang H; Wilson KE; Li P; Paulmurugan R
    Mol Imaging Biol; 2022 Apr; 24(2):333-340. PubMed ID: 34787812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast-enhanced ultrasound-guided sentinel lymph node biopsy in early-stage breast cancer: a prospective cohort study.
    Cui Q; Dai L; Li J; Shen Y; Tao H; Zhou X; Xue J
    World J Surg Oncol; 2023 May; 21(1):143. PubMed ID: 37158920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbubble detection and ultrasound-guided vacuum-assisted biopsy of axillary lymph nodes in patients with breast cancer.
    Britton P; Willsher P; Taylor K; Kilburn-Toppin F; Provenzano E; Forouhi P; Benson J; Agrawal A; Forman JR; Wallis MG
    Clin Radiol; 2017 Sep; 72(9):772-779. PubMed ID: 28427743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of contrast-enhanced ultrasound in determining the location of sentinel lymph nodes in breast cancer.
    Luo J; Feng L; Zhou Q; Chen Q; Liu J; Wu C; Luo J; Chen J; Wu H; Deng W
    Cancer Imaging; 2021 Mar; 21(1):28. PubMed ID: 33712074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.